Dubravko Kičić, Ph.D., EMBA
President of the Board
Dr. Kičić graduated from Department of Physics, Faculty of Science at University of Zagreb on applications of biomagnetism in medical diagnostics. He earned his Ph.D. degree from Helsinki University of Technology (nowadays Aalto University) on combined methods for noninvasive functional brain imaging. During his scientific career he was interested in clinical aspects of plasticity of human somato-motor nervous system.
For a number of years, as an expert in clinical neuroscience, dr. Kičić worked also as a consultant for high-tech companies involved in development and implementation of technology and methodology for non-invasive neurodiagnostics. With growing experience in biotechnology, his focus shifts towards commercial aspects of scientific research and he develops a career in management.
In healthcare company Elekta Oy (EKTA-B.ST) dr. Kičić manages an international R&D team capable of executing variety of projects financed e.g. by government funding agencies or private investors and partners. Experience with industrial and technological market in Croatia dr. Kičić gained as an Offset Business Development Manager for Finnish company Patria Land Systems.
During his career he developed expertise and competences in strategic leadership, financial structuring, project management and general business development.
His professional education he upgraded with an Executive MBA degree from Aalto Executive Education business management school in Helsinki and Singapore.
Marija Lovrić, Ph.D.
Member of the Board
Marija Lovrić graduated in 2002 and obtained her Ph.D. in 2007 in Chemistry, both from the University of Zagreb, Faculty of Science. Her Degree Thesis was made at the Ruđer Bošković Institute on preparation and spectroscopic characterization of new guanidine derivatives. Doctoral Thesis was made at the Croatian pharmaceutical company Belupo Pharmaceuticals & Cosmetics, Inc. and Josip Juraj Strossmayer University of Osijek, Faculty of Medicine on synthesis and biological evaluation of novel biaryl compounds.
She has over 12 years of experience in pharmaceutical and biotech companies mainly in the Research and Development (Belupo, GlaxoSmithKline and Galapagos) and Regulatory Affairs (Genera and Belupo). Also, at the University of Zagreb, School of Medicine she has worked on the EU FP7 Project where she was responsible for development of innovative biodegradable materials for stem cell applications in brain regeneration. She has over 10 scientific publications and has presented at several international conferences. Also, as a Business Technical and Technological Expert she is involved in the review and project evaluation.